✦ LIBER ✦

Improved survival of patients with primary distant metastatic breast cancer in the period of 1995–2008. A nationwide population-based study in the Netherlands

✍ Scribed by J. Ruiterkamp; M. F. Ernst; L. de Munck; M. van der Heiden-van der Loo; E. Bastiaannet; L. V. van de Poll-Franse; K. Bosscha; V. C. G. Tjan-Heijnen; A. C. Voogd

Publisher: Springer US
Year: 2011
Tongue: English
Weight: 289 KB
Volume: 128
Category: Article
ISSN: 0167-6806
DOI: 10.1007/s10549-011-1349-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A population-based study evaluating the

A population-based study evaluating the impact of sunitinib on overall survival in the treatment of patients with metastatic renal cell cancer

✍ Daniel Y. C. Heng; Kim N Chi; Nevin Murray; Tao Jin; Jorge A Garcia; Ronald M Bu 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 183 KB 👁 1 views

## Abstract ## BACKGROUND: Sunitinib has replaced interferon (IFN) as a first‐line standard of care in the treatment of metastatic renal cell carcinoma (RCC). This study aimed to determine overall survival and to confirm effectiveness in a population that includes poor prognosis patients. ## METH

Patient and tumor characteristics of bil

Patient and tumor characteristics of bilateral breast cancer at screening mammography in the Netherlands, a population-based study

✍ Wikke Setz-Pels; Lucien E. M. Duijm; Johanna H. Groenewoud; Marieke W. J. Louwma 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 172 KB

The impact of new chemotherapeutic and h

The impact of new chemotherapeutic and hormone agents on survival in a population-based cohort of women with metastatic breast cancer

✍ Stephen K. Chia; Caroline H. Speers; Yulia D'yachkova; Anna Kang; Suzanne Malfai 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 124 KB 👁 1 views

## Abstract ## BACKGROUND. Over the past decade, a number of new therapeutic agents have become available in the treatment of metastatic breast cancer (MBC). This study characterized the use and assessed the impact on survival of population‐based access to new agents for the treatment of MBC. ##

Second primary cancers in patients with

Second primary cancers in patients with squamous cell carcinoma of the skin: A population-based study in Sweden

✍ Cecilia Wassberg; Magnus Thörn; Jonathan Yuen; Ulrik Ringborg; Timo Hakulinen 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 French ⚖ 54 KB 👁 2 views

We studied second primary cancer among 25,947 patients diagnosed with squamous cell carcinoma of the skin (SCC) in Sweden between 1958 and 1992. In total, 5,706 patients developed a second primary cancer at any site, compared with an expected number of 2,651 [standardized incidence ratio (SIR) ‫؍‬ 2

Serum levels of 25-hydroxyvitamin D and

Serum levels of 25-hydroxyvitamin D and survival in Norwegian patients with cancer of breast, colon, lung, and lymphoma: a population-based study

✍ Steinar Tretli; Gary G. Schwartz; Peter Abusdal Torjesen; Trude Eid Robsahm 📂 Article 📅 2011 🏛 Springer Netherlands 🌐 English ⚖ 237 KB

Breast carcinoma survival in Europe and

Breast carcinoma survival in Europe and the United States : A population-based study

✍ Milena Sant; Claudia Allemani; Franco Berrino; Michel P. Coleman; Tiiu Aareleid; 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 114 KB 👁 2 views

## Abstract ## BACKGROUND Breast carcinoma survival rates were found to be higher in the U.S. than in Europe. ## METHODS Multiple regression analysis of breast carcinoma survival rates among women diagnosed between 1990 and 1992 was performed using clinical data from population‐based case series